US Patent 11008346 Beta-lactamase inhibitors
Patent 11008346 was granted and assigned to Venatorx Pharmaceuticals Inc. on May, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11008346 Beta-lactamase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
